Sarah-Jane Dawson

Sarah-Jane Dawson is an Australian clinician-scientist. She is a consultant medical oncologist and head of the Molecular Biomarkers and Translational Genomics Laboratory[1] at the Peter MacCallum Cancer Centre in Melbourne. Her current research interests are focused on the development of noninvasive blood-based biomarkers ('liquid biopsies')[2] for clinical application, including early detection, risk stratification and disease monitoring in cancer management.

Education

Dawson obtained her medical degree from the University of Melbourne in 1998, and trained as a medical oncologist in Melbourne, Australia. She completed her PhD at the University of Cambridge and performed postdoctoral studies at the Cambridge Research Institute, UK. She returned to Melbourne in 2014 to lead a research laboratory at the Peter MacCallum Cancer Centre.[1]

Scientific profile

Dawson has international recognition for her contributions to translational cancer research. A major focus of her current research involves the study of cell-free circulating tumour DNA in patients with cancer.[3] Many cancers shed small amounts of DNA (called circulating tumour DNA) into the patient's bloodstream which can be measured for clinical applications in cancer management. Dawson's recent research has shown the application of circulating tumour DNA testing for disease monitoring in various cancer types. She has received ongoing support from high-profile Australian organisations including the National Health and Medical Research Council (NHMRC), National Breast Cancer Foundation, Leukaemia and Lymphoma Society and Australian Cancer Research Foundation.

References
  1. "Sarah-Jane Dawson". Peter MacCallum Cancer Centre. Retrieved 2017-08-25.
  2. "World-first liquid biopsy for blood cancers promises less invasive, more precise and effective treatments". Peter MacCallum Cancer Centre. Retrieved 2017-08-25.
  3. "Blood test hope for cancer patients". Retrieved 2017-08-25.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.